Cocaine (Tropane Alkaloid · Dopamine Reuptake Inhibitor · Local Anaesthetic · Informational)

Compound	Cocaine (Benzoylmethylecgonine)
Chemical class	Alkaloid — Tropane (Benzoate ester of ecgonine methyl ester)
CAS	50-36-2
Primary source	Erythroxylum coca (coca plant, leaves)
Key applications	Controlled Schedule I/II; local anaesthetic (topical ENT use only); illicit drug; informational reference
Claim strength	High (as pharmaceutical local anaesthetic for ENT); Informational only
Typical form	Pharmaceutical topical solution (4% ENT anaesthetic); Schedule II controlled; illegal illicit drug
Buy from Herbuno	Browse HerbIQ Compound Index →

Name origin: From kuka (Quechua name for the coca plant) → Spanish coca → cocaine (German chemist Albert Niemann, who first isolated it in 1860, proposed the name). Cocaine is a tropane ester — specifically the methyl ester of benzoylecgonine. It is the primary bioactive alkaloid of Erythroxylum coca leaves, constituting approximately 0.5–1% of dry leaf weight. Historical significance: Cocaine has one of the most culturally complex histories of any natural product. Coca leaf chewing has been practiced in Andean cultures for at least 4,000 years — for altitude acclimatisation, endurance, and spiritual purposes. European introduction of cocaine occurred after Niemann’s 1860 isolation: Sigmund Freud published “Über Coca” (1884) praising its antidepressant properties; Karl Koller demonstrated topical ocular anaesthesia (1884) — the first local anaesthetic; Coca-Cola contained cocaine from 1886 until 1903; William Halsted (father of American surgery) became addicted while developing nerve block cocaine anaesthesia. The recognition of cocaine’s addiction liability and its replacement by less addictive synthetic local anaesthetics (procaine, lidocaine) dramatically reduced legitimate use. Pharmacology: Cocaine blocks reuptake transporters for dopamine (DAT), norepinephrine (NET), and serotonin (SERT) simultaneously, producing euphoria via massive dopamine surge in the nucleus accumbens. It is also a voltage-gated sodium channel blocker — the basis for local anaesthetic activity. Regulatory status: Schedule II (US, legitimate pharmaceutical for ENT); Schedule I (illegal). Illicit cocaine is one of the most widely abused drugs globally (approximately 18–20 million users annually).

---

Cocaine — Pharmacological and Historical Context

Local anaesthetic — only remaining pharmaceutical use: Cocaine 4% topical solution remains the only pharmaceutical use of cocaine — applied to the nasal mucosa for ENT procedures. It is the only local anaesthetic that simultaneously produces vasoconstriction (via norepinephrine reuptake inhibition) and anaesthesia — useful in nasal surgery where both are needed. All other cocaine applications have been replaced by synthetic local anaesthetics (lidocaine, bupivacaine) that are equally effective without addiction potential. Pharmaceutical evidence: High (for topical ENT anaesthesia).

Addiction mechanism — triple reuptake inhibition: Cocaine’s simultaneous inhibition of DAT, NET, and SERT produces an extraordinarily powerful dopamine surge in the nucleus accumbens (the brain’s reward centre). Peak euphoria occurs within seconds of nasal insufflation or IV injection and lasts 20–30 minutes — the rapid offset driving binge use. Cocaine is one of the most addictive substances known, with animal self-administration models showing monkeys preferring cocaine to food to the point of starvation. Critical pharmacology reference.

Coca leaf — traditional use vs cocaine: Coca leaf chewing (approximately 0.5 g cocaine per 100 g dry leaf, absorbed very slowly) produces mild stimulation comparable to moderate caffeine without the intense euphoria or addiction potential of concentrated cocaine. Andean nations (Bolivia, Peru) have maintained coca leaf as a legal traditional cultural and agricultural product. WHO recognised coca leaf as distinct from cocaine and the 1961 Single Convention exemption for traditional coca use has been increasingly respected. Ethnobotanical reference.

---

Frequently Asked Questions — Cocaine

Why is cocaine still used medically when it is a dangerous drug of abuse?
Cocaine’s unique combination of topical local anaesthesia AND vasoconstriction makes it irreplaceable in certain ENT surgical contexts where both properties are simultaneously needed — particularly nasal mucosal procedures where bleeding control is critical. Alternative topical anaesthetics (lidocaine) do not produce vasoconstriction; vasoconstricting agents (epinephrine) are not local anaesthetics. The cocaine 4% topical solution used in ENT is not systemically absorbed to significant extent when applied correctly and has acceptable safety profile in this limited indication.

Did Coca-Cola originally contain cocaine?
Yes — the original Coca-Cola (patented 1886 by John Pemberton) contained an extract of coca leaves (containing cocaine) alongside caffeine from kola nuts. Estimated cocaine content was approximately 9 mg per glass in the original formula. The coca leaf extract was retained in the formula but cocaine was removed by 1903 (prior to cocaine prohibition) in response to growing concerns about cocaine addiction. Coca-Cola still contains a “spent” coca leaf extract (decocainised coca leaf flavour) that provides the characteristic subtle flavour notes — the sole remaining commercial use of coca leaf in the US is for this purpose, under DEA Schedule II permit held by the Stepan Company.

What is crack cocaine and how does it differ from powder cocaine?
Powder cocaine (cocaine hydrochloride salt) cannot be smoked — it decomposes at temperatures below vaporisation. Crack cocaine is the freebase form — cocaine hydrochloride converted to free base by treatment with sodium bicarbonate and water, then dried. Crack freebase vaporises at lower temperatures, enabling inhalation. Smoked crack cocaine produces a faster, more intense peak than nasal insufflation of powder cocaine (seconds vs minutes), dramatically increasing addiction potential. The characteristic crackling sound when smoked gives crack cocaine its name. The pharmacological differences between powder and crack cocaine are entirely about route of administration and absorption rate — the molecule is identical.

Is there any treatment for cocaine addiction?
Unlike opioid addiction (with buprenorphine, methadone) or nicotine addiction (with NRT, varenicline), no FDA-approved pharmacological treatment exists for cocaine addiction. This represents a major unmet medical need — cocaine use disorder affects millions globally without a medication equivalent to substitution therapy for opioids. Research approaches under investigation: disulfiram (reduces cocaine high), propranolol (reduces craving), N-acetylcysteine (glutamate modulation), and several immunotherapy approaches (anti-cocaine vaccines). Cognitive behavioural therapy is the most evidence-supported intervention currently available.

Related compounds: Atropine, Scopolamine, Nicotine, Morphine

---

Claim-strength scale – High = multiple human RCTs; Moderate = limited trials or strong preclinical convergence; Emerging = early-stage lab or animal data.

← HerbIQ Compound Index · HerbIQ P02: Extraction · HerbIQ P03: Delivery